Nokea
A nurse should advise a client beginning therapy with testosterone (Androderm) about which of the following adverse effects? Select all that apply.
- A. Impotence
- B. Fluid retention
- C. Male-pattern baldness
- D. Somnolence
- E. Mania
Correct Answer: A,B,C
Rationale: A nurse should advise a client beginning therapy with testosterone (Androderm) of the following adverse effects: gynecomastia, testicular atrophy, inhibition of testicular function, impotence, enlargement of the penis, nausea, vomiting, jaundice, headache, anxiety, male-pattern baldness, acne, depression, and fluid and electrolyte imbalances (which include sodium, water, chloride, potassium, calcium, and phosphate retention).
You may also like to solve these questions
A client taking oral contraceptive drugs complains of occasional bloating of the abdomen. Which of the following instructions should the nurse offer the client to help alleviate the condition?
- A. Limit fluid intake with meals.
- B. Take the drug along with food.
- C. Decrease the intake of salt.
- D. Elevate the legs when sitting.
Correct Answer: A
Rationale: The nurse should instruct the client to limit fluid intake with meals if she experiences bloating of the abdomen after oral contraceptive use. Light to moderate exercise also may be helpful. Taking the drug with food alleviates nausea and GI irritation, and not the bloating of the abdomen. A decrease in salt intake causes a decrease in the intake of sodium, which may be beneficial when there is an excess fluid volume, and not when there is bloating of the abdomen. Elevating the legs when sitting prevents thromboembolism seen with oral contraceptive use. It does not prevent bloating of the abdomen.
A client with progestin excess may report which of the following symptoms to the nurse during ongoing assessment during treatment with Estrostep Fe? Select all that apply.
- A. Amenorrhea
- B. Late breakthrough bleeding
- C. Hair loss
- D. Weight gain
- E. Hirsutism
Correct Answer: C,D,E
Rationale: Signs of excess progestin include increased appetite, weight gain, tiredness, fatigue, hypomenorrhea, acne, oily scalp, hair loss, hirsutism, depression, monilial vaginitis, and breast regression.
A client has a levonorgestrel implant contraceptive system inserted. The nurse understands that this type of contraceptive provides protection for how long?
- A. 1 year
- B. 2 years
- C. 5 years
- D. 8 years
Correct Answer: C
Rationale: Levonorgestrel, a progestin, is available as an implant contraceptive system (Norplant System). Six capsules, each containing levonorgestrel, are implanted using local anesthesia in the subdermal (below the skin) tissues of the midportion of the upper arm. The capsules provide contraceptive protection for 5 years but may be removed at any time at the request of the patient.
A female client receiving fluoxymesterone for metastatic breast cancer is disturbed by the physical changes seen in her body. The nurse provides support to the client based on assessment of which of the following features the client is experiencing related to this therapy?
- A. Deepening of the voice
- B. Hypopigmentation of the skin
- C. Decrease in clitoris size
- D. Increase in body weight
Correct Answer: A
Rationale: Deepening of the voice may be seen as a feature of virilization following male hormone therapy in a female client. Virilization is the acquisition of male characteristics in the female. Other features of virilization include pigmentation, and not hypopigmentation, of the skin and an increase, not a decrease, in the size of the clitoris. An increase in body weight is not a sign of virilization. It may occur due to impaired nutrition of the body.
When completing the ongoing assessment of clients receiving estrogen, progestin, or combination products, which of the following would the nurse include? Select all that apply.
- A. Blood pressure
- B. Pulse
- C. Respiratory rate
- D. Temperature
- E. Therapeutic effects
Correct Answer: A,B,C,E
Rationale: The nurse's ongoing assessment of clients receiving estrogen, progestin, or combination products should include blood pressure, pulse, respiratory rate, weight, and questioning about adverse effects and therapeutic effects.